Prion diseases are transmissible, neurodegenerative disorders associat
ed with as yet incompletely defined isoforms of a cellular protein ter
med prion protein (PrP). We have now identified in PrP structural info
rmation compatible with nucleotide- and nucleic acid-binding. As such,
PrP contains a putative nicotinamide adenine dinucleotide (NADH)-bind
ing site. Moreover, the PrP octarepeats reveal homology to the nucleic
acid-binding and strand-annealing octarepeats of mammalian heterogene
ous ribonucleoprotein (RNP) A1. Therefore, PrP may have NADH-dependent
oxidoreductase activity as well as A1-like functions such as nucleic
acid annealing and splicing. Moreover, we propose that infectious prio
ns are propagated through a dynamic molecular symbiosis between a ribo
zyme-like nucleic acid and a conformational isomer of the RNP-like pri
on protein. Thus, our model has important implications for the underst
anding and treatment of prion diseases.